Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.
Simona BiscariniSimone VillaCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaNathalie IannottiMatteo BolisBianca MarianiAntonia Grazia ValzanoLetizia Corinna MorlacchiFrancesca DonatoGiuseppe CastellanoRamona CassinMaria CarrabbaAntonio MuscatelloAndrea GoriAlessandra BanderaAndrea LombardiPublished in: Biomedicines (2022)
RMD and mAbs have minimal ADRs and favourable outcomes in immunocompromised patients.